期刊文献+

上皮性卵巢癌PTEN启动子CpG岛甲基化研究 被引量:1

Study on the Promoter Methylation of FTEN Gene in Epithelial Ovarian Carcinoma
下载PDF
导出
摘要 目的探讨上皮性卵巢癌中抑癌基因PTEN启动子CpG岛的甲基化情况。方法选用甲基化敏感性核酸内切酶HpaⅡ酶切-PCR法,检测64例上皮性卵巢癌组织(浆液性卵巢襄47例,粘液性卵巢癌17例)以及12例正常卵巢组织中PTEN启动子CpG岛甲基化情况。结果正常卵巢组织、浆液性卵巢癌组织和粘液性卵巢癌组织中PTEN启动子甲基化阳性率分别为8.33%(1/12)、57.45%(27/47)和47.06%(8/17),浆液性和粘液性这两种不同组织学类型的上皮性卵巢癌之间的差异无显著性(P<0.05),但均与正常组织间有显著性差异(P分别<0.01,0.05)。结论 PTEN启动子CpG岛甲基化在浆液性卵巢癌和粘液性卵巢癌中均有很高的发生率,提示PTEN基因启动子异常甲基化可能是其在卵巢癌中主要灭活机制之一。 Objective To explor the promoter methylation of PTEN gene in human epithelial ovarian carcinoma.Methods The promoter methylation of PTEN gene CpG islands from 47 cases of serous cystadenocarcinoma,17cases of mucinous cystadenocarcinoma and 12 of normal subjects was analyzed by using methylation sensitive endonuclease Hpa II-PCR method.Results Promoter of PTEN gene was methylated in 8.33%(l/12)of normal subjects,57.45% (27/47)of serous cystadenocarcinoma,and 47.06% (8/17)of mucinous cystadenocarcinoma.The promoter methylation of PTEN gene in both serous cystadenocarcinoma and mucinous cystadenocarcinoma is much higher as compared with normal o-varian n皊sus(P<0.01,0.05,respectively),and no difference between serous cystadenocarcinoma and mucinous cystandenocarnoma was observed (P> 0.05).Conclusion The promoter methylation of PTEN gene CpG islands occurs very common in both serous cystadenocarcinoma and mucinous cystaenocarcinoma,indicating that abnormal promoter methylation is one of the prodominant inactivation mechanismi of the PTEN gene and may be associated with pathogenesis of human ovarian carcinoma.
出处 《医学研究通讯》 2004年第4期50-51,共2页 Bulletin of Medical Research
基金 2001年宁波市级课题
关键词 上皮性卵巢癌 PTEN启动子 CPG岛 甲基化 Ovarian Carcinoma PTEN Gene Promoter Methylation
  • 相关文献

参考文献4

  • 1[1]Fan X, et al. PTEN, DMBT1, and p16 alterations in diffusely infltraing astocytomas.Int J Oncol,2002,21 (3) :667 - 64.
  • 2[2]Sato K,et al Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virc hows Arch,2002,440(2): 160- 5.
  • 3[3]Fujii H,et al. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and mi~llite instability. Hum Pathol,2002,33(4) :421 - 8.
  • 4[4]Saga Y, et al. Overspression of PTEN increases sensitivity to SN - 38,an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells. Clin Cancer Res,2002,8(5): 1248 - 52.

同被引文献11

  • 1Fox H, Agrawal K, Langley FA. A clinicopathologic study of 92 cases of gTanulosa cell tumor of ovary with special referenced to the factors influencing prognosis [ J ]. Cancer, 1975,35 ( 1 ) : 231 -241.
  • 2Sate N, Tsunoda H, Nishida M, et al. Loss of heterozygosity on 10q23. 3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign cndometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary [ J ]. Cancer Res,2000,60 ( 24 ) : 7052 - 7056.
  • 3Sakurada A, Suzuki A, SatoM, et al. Genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancer of the breast,lung, pancreas, stomach, and ovary [ J ]. Jpn J Cancer Res, 1997,88 : 1025 - 1028.
  • 4Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumor suppressor gene, PTEN ( MMAC1 ) , at chromosome 10q23.3 that is mutated in multiple advanced cancer[ J]. Nat Genet, 1997,15:356 - 362.
  • 5Konopka B, Janiec JA, Czapczak D. Molecular genetic defects in endometrial carcinomas : Microsatellite instability, PTEN and beta- catenin( CTNNB1 ) genes mutations[ J]. Cancer Res Clin Oncol, 2007,133(6) :361 -371.
  • 6Risinger JI,Hayes K,Maxwell GL,et al. PTEN mutation in endo- metrial cancers is associated with favorable clinical and pathologic characteristics[ J]. Clin Cancer Re, s, 1998,4:3005 - 3010.
  • 7Saito M, Okanoto A, Kohno T, et al. Allelic imbalance and mutations of the PTEN gene in ovarian cancer[ J ]. Int J Cancer,2000, 85 : 160 - 165.
  • 8Hali PA. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections:an index of cell proliferation with evidence of deregulated expression in some neoplasms[ J]. J Pathol, 1990,162(4) :285.
  • 9Cheney IW, Johnson DE, Vaillancourt MT, et al. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer [ J ]. Cancer Res, 1998,58 ( 11 ) : 2331 - 2334.
  • 10孙理.PTEN和HER-2/neu在上皮性卵巢癌组织中的表达及相关性[J].实用肿瘤学杂志,2008,22(3):229-232. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部